Metabolic syndrome and the risk of calcium stones

Khashayar Sakhaee, Giovanna Capolongo, Naim M. Maalouf, Andreas Pasch, Orson W. Moe, John Poindexter, Beverley Adams-Huet

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background. The metabolic syndrome (MS) is associated with increased prevalence of kidney stones, yet the specific stone type remains largely unknown. This study was conducted to assess whether risk factors associated with calcium nephrolithiasis increase with individual characteristics of the MS. Methods. A retrospective analysis was performed in 109 non-stone-forming subjects and 128 recurrent calcium stone formers from Dallas, Texas. A separate analysis was performed in 140 recurrent calcium stone formers from Bern, Switzerland. Demographic, anthropometric, serum and urinary profiles were measured. Results. In non-stone formers from Dallas, urinary calcium (3.6 ± 1.8 to 6.0 ± 2.9 mmol/day, P 0.0003 for trend, zero to four features) increased with increasing features of the MS. This change was attendant with a significant rise in supersaturation index (SI) of calcium oxalate (CaOx) (2.76 ± 1.21 to 4.45 ± 1.65, P < 0.0001; zero to four features). In calcium stone formers from Dallas, urinary calcium marginally increased (5.2 ± 2.3 to 7.0 ± 4.0 mmol/day, P 0.09; zero to four features), while urinary oxalate (356 ± 141 to 504 ± 203 μmol/day, P 0.001; zero to four features) and SI CaOx (4.46 ± 1.80 to 6.16 ± 3.71, P 0.009; zero to four features) significantly increased with features of the MS. However, when adjusted for confounding variables such as total volume, age, gender, urine sodium and urine sulfate, urinary calcium and SI CaOx showed no significant changes in stone formers yet remained significant in non-stone formers. In a separate cohort from Bern, Switzerland urinary calcium (6.9 ± 3.6 versus 7.0 ± 3.2, P 0.8) and SI CaOx (3.37 ± 1.98 versus 4.04 ± 2.78, P 0.5) did not differ between subjects with and without the MS. Conclusion. sIn non-stone formers, the risk of CaOx stone formation increases with the number of features of the MS. However, in stone-forming subjects, the propensity for CaOx precipitation is much higher but is not independently associated with increasing features of the MS.

Original languageEnglish (US)
Pages (from-to)3201-3209
Number of pages9
JournalNephrology Dialysis Transplantation
Volume27
Issue number8
DOIs
StatePublished - Aug 2012

Fingerprint

Calcium Oxalate
Calcium
Switzerland
Urine
Nephrolithiasis
Kidney Calculi
Confounding Factors (Epidemiology)
Oxalates
Demography
Serum

Keywords

  • kidney stone
  • metabolic syndrome
  • nephrolithiasis
  • obesity

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Metabolic syndrome and the risk of calcium stones. / Sakhaee, Khashayar; Capolongo, Giovanna; Maalouf, Naim M.; Pasch, Andreas; Moe, Orson W.; Poindexter, John; Adams-Huet, Beverley.

In: Nephrology Dialysis Transplantation, Vol. 27, No. 8, 08.2012, p. 3201-3209.

Research output: Contribution to journalArticle

Sakhaee, Khashayar ; Capolongo, Giovanna ; Maalouf, Naim M. ; Pasch, Andreas ; Moe, Orson W. ; Poindexter, John ; Adams-Huet, Beverley. / Metabolic syndrome and the risk of calcium stones. In: Nephrology Dialysis Transplantation. 2012 ; Vol. 27, No. 8. pp. 3201-3209.
@article{7c055d97e9624332825b62adcfc699c8,
title = "Metabolic syndrome and the risk of calcium stones",
abstract = "Background. The metabolic syndrome (MS) is associated with increased prevalence of kidney stones, yet the specific stone type remains largely unknown. This study was conducted to assess whether risk factors associated with calcium nephrolithiasis increase with individual characteristics of the MS. Methods. A retrospective analysis was performed in 109 non-stone-forming subjects and 128 recurrent calcium stone formers from Dallas, Texas. A separate analysis was performed in 140 recurrent calcium stone formers from Bern, Switzerland. Demographic, anthropometric, serum and urinary profiles were measured. Results. In non-stone formers from Dallas, urinary calcium (3.6 ± 1.8 to 6.0 ± 2.9 mmol/day, P 0.0003 for trend, zero to four features) increased with increasing features of the MS. This change was attendant with a significant rise in supersaturation index (SI) of calcium oxalate (CaOx) (2.76 ± 1.21 to 4.45 ± 1.65, P < 0.0001; zero to four features). In calcium stone formers from Dallas, urinary calcium marginally increased (5.2 ± 2.3 to 7.0 ± 4.0 mmol/day, P 0.09; zero to four features), while urinary oxalate (356 ± 141 to 504 ± 203 μmol/day, P 0.001; zero to four features) and SI CaOx (4.46 ± 1.80 to 6.16 ± 3.71, P 0.009; zero to four features) significantly increased with features of the MS. However, when adjusted for confounding variables such as total volume, age, gender, urine sodium and urine sulfate, urinary calcium and SI CaOx showed no significant changes in stone formers yet remained significant in non-stone formers. In a separate cohort from Bern, Switzerland urinary calcium (6.9 ± 3.6 versus 7.0 ± 3.2, P 0.8) and SI CaOx (3.37 ± 1.98 versus 4.04 ± 2.78, P 0.5) did not differ between subjects with and without the MS. Conclusion. sIn non-stone formers, the risk of CaOx stone formation increases with the number of features of the MS. However, in stone-forming subjects, the propensity for CaOx precipitation is much higher but is not independently associated with increasing features of the MS.",
keywords = "kidney stone, metabolic syndrome, nephrolithiasis, obesity",
author = "Khashayar Sakhaee and Giovanna Capolongo and Maalouf, {Naim M.} and Andreas Pasch and Moe, {Orson W.} and John Poindexter and Beverley Adams-Huet",
year = "2012",
month = "8",
doi = "10.1093/ndt/gfr703",
language = "English (US)",
volume = "27",
pages = "3201--3209",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Metabolic syndrome and the risk of calcium stones

AU - Sakhaee, Khashayar

AU - Capolongo, Giovanna

AU - Maalouf, Naim M.

AU - Pasch, Andreas

AU - Moe, Orson W.

AU - Poindexter, John

AU - Adams-Huet, Beverley

PY - 2012/8

Y1 - 2012/8

N2 - Background. The metabolic syndrome (MS) is associated with increased prevalence of kidney stones, yet the specific stone type remains largely unknown. This study was conducted to assess whether risk factors associated with calcium nephrolithiasis increase with individual characteristics of the MS. Methods. A retrospective analysis was performed in 109 non-stone-forming subjects and 128 recurrent calcium stone formers from Dallas, Texas. A separate analysis was performed in 140 recurrent calcium stone formers from Bern, Switzerland. Demographic, anthropometric, serum and urinary profiles were measured. Results. In non-stone formers from Dallas, urinary calcium (3.6 ± 1.8 to 6.0 ± 2.9 mmol/day, P 0.0003 for trend, zero to four features) increased with increasing features of the MS. This change was attendant with a significant rise in supersaturation index (SI) of calcium oxalate (CaOx) (2.76 ± 1.21 to 4.45 ± 1.65, P < 0.0001; zero to four features). In calcium stone formers from Dallas, urinary calcium marginally increased (5.2 ± 2.3 to 7.0 ± 4.0 mmol/day, P 0.09; zero to four features), while urinary oxalate (356 ± 141 to 504 ± 203 μmol/day, P 0.001; zero to four features) and SI CaOx (4.46 ± 1.80 to 6.16 ± 3.71, P 0.009; zero to four features) significantly increased with features of the MS. However, when adjusted for confounding variables such as total volume, age, gender, urine sodium and urine sulfate, urinary calcium and SI CaOx showed no significant changes in stone formers yet remained significant in non-stone formers. In a separate cohort from Bern, Switzerland urinary calcium (6.9 ± 3.6 versus 7.0 ± 3.2, P 0.8) and SI CaOx (3.37 ± 1.98 versus 4.04 ± 2.78, P 0.5) did not differ between subjects with and without the MS. Conclusion. sIn non-stone formers, the risk of CaOx stone formation increases with the number of features of the MS. However, in stone-forming subjects, the propensity for CaOx precipitation is much higher but is not independently associated with increasing features of the MS.

AB - Background. The metabolic syndrome (MS) is associated with increased prevalence of kidney stones, yet the specific stone type remains largely unknown. This study was conducted to assess whether risk factors associated with calcium nephrolithiasis increase with individual characteristics of the MS. Methods. A retrospective analysis was performed in 109 non-stone-forming subjects and 128 recurrent calcium stone formers from Dallas, Texas. A separate analysis was performed in 140 recurrent calcium stone formers from Bern, Switzerland. Demographic, anthropometric, serum and urinary profiles were measured. Results. In non-stone formers from Dallas, urinary calcium (3.6 ± 1.8 to 6.0 ± 2.9 mmol/day, P 0.0003 for trend, zero to four features) increased with increasing features of the MS. This change was attendant with a significant rise in supersaturation index (SI) of calcium oxalate (CaOx) (2.76 ± 1.21 to 4.45 ± 1.65, P < 0.0001; zero to four features). In calcium stone formers from Dallas, urinary calcium marginally increased (5.2 ± 2.3 to 7.0 ± 4.0 mmol/day, P 0.09; zero to four features), while urinary oxalate (356 ± 141 to 504 ± 203 μmol/day, P 0.001; zero to four features) and SI CaOx (4.46 ± 1.80 to 6.16 ± 3.71, P 0.009; zero to four features) significantly increased with features of the MS. However, when adjusted for confounding variables such as total volume, age, gender, urine sodium and urine sulfate, urinary calcium and SI CaOx showed no significant changes in stone formers yet remained significant in non-stone formers. In a separate cohort from Bern, Switzerland urinary calcium (6.9 ± 3.6 versus 7.0 ± 3.2, P 0.8) and SI CaOx (3.37 ± 1.98 versus 4.04 ± 2.78, P 0.5) did not differ between subjects with and without the MS. Conclusion. sIn non-stone formers, the risk of CaOx stone formation increases with the number of features of the MS. However, in stone-forming subjects, the propensity for CaOx precipitation is much higher but is not independently associated with increasing features of the MS.

KW - kidney stone

KW - metabolic syndrome

KW - nephrolithiasis

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=84864624241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864624241&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfr703

DO - 10.1093/ndt/gfr703

M3 - Article

VL - 27

SP - 3201

EP - 3209

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 8

ER -